NCT01876277

Brief Summary

In adolescence, the effects of cancer and its treatment can lead to bodily changes such as hair loss, weight loss or gain, amputations, scars and developmental delay. As treatments for childhood cancers improve and life expectancy increases, more adolescents have to deal with the effects of cancer and the treatment on their bodies throughout their lives. Body image can be defined as "The mental image we hold of our bodies". There are two aspects to this, how we "see" our size/shape/weight etc, and then how we feel about this. Often the actual change in body does not always predict how people cope with it, or how they feel about it. Prior research suggests, and clinical experiences suggests that body image issues arise for at least some adolescents with cancer, however it is unknown whether a disturbance in body image is seen as distressing for the adolescent, or how this affects them psychologically. Body image problems were always seen as a typically female problem, and therefore researchers have often neglected to look at the issues for men. There is currently no research specifically addressing the impact of body image in adolescent boys with cancer. This research will involve interviewing adolescent males with cancer with the aims to find out;

  1. 1.What the body image issues are, if any for this group.
  2. 2.How any body image issues might affect them, particularly psychologically.
  3. 3.What helps or hinders this group maintain a positive body image, or stop it having a negative impact on them psychologically.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

June 10, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 12, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
Last Updated

July 22, 2024

Status Verified

July 1, 2024

Enrollment Period

11 months

First QC Date

June 10, 2013

Last Update Submit

July 19, 2024

Conditions

Keywords

CancerBody imageAdolescent

Outcome Measures

Primary Outcomes (1)

  • Qualitative Interview Schedule

    Interview schedule developed by researcher to act as topic guide for interview.

    1 hour

Study Arms (1)

Adolescent males with cancer

Males aged 13-21 who have been treated at the Royal Marsden Hospital for cancer.

Eligibility Criteria

Age13 Years - 21 Years
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Adolescent males who have been treated for cancer at the Royal Marsden Hospital within the past 5 years.

You may qualify if:

  • Male- as this research has identified a need for research with this particular group.
  • Aged between 13 and 21 (inclusive)as this research is focussing on adolescents and we have defined the age range of adolescence as 13 to 21, in line with other research on adolescence.
  • Have a diagnosis of cancer (any type)as this study is not focussing on any particular type of cancer and this will ensure a sufficient pool of participants.
  • Have been diagnosed for at least 6 months as issues about adjusting to the diagnosis will be less prevalent at this time and they are likely to have received some treatment for cancer which often produces some of the bodily changes that may affect their body image.
  • Have a prognosis of more than 3 months, as it would be unethical to interview people in the final stages of terminal cancer as end of life issues would be more prevalent. Three months was decided upon because often this is the length of time given to patients when it is decided that treatment is no longer indicated and their illness is considered terminal. We would not contact anyone whose cancer was considered terminal.
  • Have had treatment within the past 5 years, because beyond this time they are less likely to have body image issues and other issues or than cancer could be more prevalent for them, so they are not suitable participants.
  • Able to participate in the interview verbally and in English because the qualitative method requires detailed analysis of the texts and translation may lead to a loss in some of the meaning that is crucial for this research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Marsden Hopstial

Sutton, London, SM2 5PT, United Kingdom

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Annabel Christopher, BSc

    University of Surrey

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2013

First Posted

June 12, 2013

Study Start

June 1, 2013

Primary Completion

May 1, 2014

Study Completion

May 1, 2014

Last Updated

July 22, 2024

Record last verified: 2024-07

Locations